Cynosure, Inc.  

(Public, NASDAQ:CYNO)   Watch this stock  
Find more results for CYNO
29.32
+0.32 (1.10%)
Dec 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 28.59 - 29.50
52 week 18.63 - 31.48
Open 29.00
Vol / Avg. 270,190.00/182,015.00
Mkt cap 629.94M
P/E 41.40
Div/yield     -
EPS 0.71
Shares 21.65M
Beta 1.51
Inst. own 84%
Feb 10, 2015
Q4 2014 Cynosure Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 20, 2014
Cynosure Inc. at Canaccord Genuity Medical Technologies & Diagnostics Forum - Webcast
Oct 28, 2014
Q3 2014 Cynosure Inc Earnings Release
Oct 28, 2014
Q3 2014 Cynosure Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 4.30% -0.73%
Operating margin 7.34% -2.58%
EBITD margin - 15.48%
Return on average assets 2.86% -0.51%
Return on average equity 3.66% -0.63%
Employees 576 -
CDP Score - -

Address

5 Carlisle Road
WESTFORD, MA 01886
United States - Map
+1-978-2564200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cynosure Inc. (Cynosure) develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair rejuvenate the skin through the treatment of vascular and pigmented lesions, remove multi-colored tattoos, liquefy and remove unwanted fat through laser lypolysis, reduce cellulite and treat onychomycosis. The Company�s systems includes a range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag and diode lasers, as well as intense pulsed light. It offers single energy source systems, as well as workstations that include two or more different types of lasers or pulsed light technologies. In September 2014, the Company acquired the assets of Ellman International, Inc.

Officers and directors

Michael R. Davin Chairman of the Board, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy W. Baker President, Chief Financial Officer, Chief Operating Officer, Treasurer
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas J. Delaney Executive Vice President - Worldwide Sales
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William O. Flannery Director
Age: 68
Bio & Compensation  - Reuters
Brian M. Barefoot Independent Director
Age: 70
Bio & Compensation  - Reuters
Ettore V. Biagioni Independent Director
Age: 55
Bio & Compensation  - Reuters
Marina Hatsopoulos Independent Director
Age: 48
Bio & Compensation  - Reuters
Thomas H. Robinson Independent Director
Age: 55
Bio & Compensation  - Reuters